Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.G. R. Hudes, C McAleer, Richard E. Greenberg et al.|Journal of Clinical Oncology|1997Cited by 273
Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.Edward R. Sauter, Meenhard Herlyn, M. Nesbit et al.|PubMed|1999Cited by 186
Simultaneous Expression of Furin and Vascular Endothelial Growth Factor in Human Oral Tongue Squamous Cell Carcinoma ProgressionRicardo López de Cicco, Andrés J. Klein-Szanto, Samuel Litwin et al.|Clinical Cancer Research|2004Cited by 87